Ricard Mesia

Summary

Country: Spain

Publications

  1. ncbi Rapid palliation of symptoms with platinum-based chemotherapy plus cetuximab in recurrent oral cancer: a case report
    Ricard Mesia
    Medical Oncology Department, Institut Català d Oncologia ICO, Hospitalet de Llobregat, Barcelona, Spain
    Head Neck Oncol 2:3. 2010
  2. ncbi SEOM clinical guidelines for the treatment of head and neck cancer
    Ricard Mesía Nin
    Servicio de Oncologia Medica, Institut Catala d Oncologia, L Hospitalet de Llobregat, Barcelona, Spain
    Clin Transl Oncol 12:742-8. 2010
  3. ncbi Phase I/II docetaxel plus concurrent hyperfractionated radiotherapy in locally advanced unresectable head and neck cancer (TAX.ES1.102 study)
    Agusti Barnadas
    Department of Medical Oncology, Institut Catala d Oncologia, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain
    Clin Transl Oncol 13:254-60. 2011
  4. ncbi Hyperfractionated radiotherapy: improvement of survival in locally advanced nasopharyngeal carcinoma
    Ricard Mesia
    Department of Medical Oncology, L Hospitalet de Llobregat, Barcelona, Spain
    Ann Otol Rhinol Laryngol 118:442-8. 2009
  5. ncbi The use of caspase inhibitors in pulsed-field gel electrophoresis may improve the estimation of radiation-induced DNA repair and apoptosis
    Josep Balart
    Translational Research Laboratory IDIBELL, Institut Catala d Oncologia, L Hospitalet de Llobregat, Spain
    Radiat Oncol 6:6. 2011
  6. ncbi Cetuximab may inhibit tumor growth and angiogenesis induced by ionizing radiation: a preclinical rationale for maintenance treatment after radiotherapy
    Gemma Pueyo
    Laboratori de Recerca Translacional IDIBELL, Catalan Institute of Oncology, L Hospitalet de Llobregat, Spain
    Oncologist 15:976-86. 2010
  7. ncbi Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma
    Margarita Majem
    Department of Medical Oncology, L Hospitalet de Llobregat, Barcelona, Spain
    Laryngoscope 116:1651-6. 2006

Collaborators

  • Josep Balart
  • Oriol Casanovas
  • Margarita Majem
  • Agusti Barnadas
  • Gemma Pueyo
  • Ricard Mesía Nin
  • Ramon Galiana
  • Ariadna Lloansí
  • Vicente Valentí
  • Mireia Margeli
  • Lluís Anglada
  • Antonio Arellano
  • Antonio Lopez-Pousa
  • José M de Vega
  • Miguel Pastor Borgoñón
  • Dolores Isla Casado
  • Marta Baro
  • Agnes Figueras
  • Silvia Vazquez
  • Gabriel Capella
  • Juan Jesús Cruz Hernández
  • Alicia Lozano
  • Ana Montes
  • Julio Nogues
  • Felipe Cardenal
  • Francisco Javier Perez
  • Josep Ramon Germa Llluch
  • Joaquin Gomez
  • Amparo Juan
  • Manel Maños

Detail Information

Publications7

  1. ncbi Rapid palliation of symptoms with platinum-based chemotherapy plus cetuximab in recurrent oral cancer: a case report
    Ricard Mesia
    Medical Oncology Department, Institut Català d Oncologia ICO, Hospitalet de Llobregat, Barcelona, Spain
    Head Neck Oncol 2:3. 2010
    ....
  2. ncbi SEOM clinical guidelines for the treatment of head and neck cancer
    Ricard Mesía Nin
    Servicio de Oncologia Medica, Institut Catala d Oncologia, L Hospitalet de Llobregat, Barcelona, Spain
    Clin Transl Oncol 12:742-8. 2010
    ....
  3. ncbi Phase I/II docetaxel plus concurrent hyperfractionated radiotherapy in locally advanced unresectable head and neck cancer (TAX.ES1.102 study)
    Agusti Barnadas
    Department of Medical Oncology, Institut Catala d Oncologia, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain
    Clin Transl Oncol 13:254-60. 2011
    ..Concurrent chemotherapy and radiotherapy is recommended for the treatment of locally advanced unresectable head and neck (H&N) cancer...
  4. ncbi Hyperfractionated radiotherapy: improvement of survival in locally advanced nasopharyngeal carcinoma
    Ricard Mesia
    Department of Medical Oncology, L Hospitalet de Llobregat, Barcelona, Spain
    Ann Otol Rhinol Laryngol 118:442-8. 2009
    ..Adding induction CT may control distant metastasis. Here we compare the results of our protocol with induction CT followed by HFRT alone with the results obtained with concomitant treatments...
  5. ncbi The use of caspase inhibitors in pulsed-field gel electrophoresis may improve the estimation of radiation-induced DNA repair and apoptosis
    Josep Balart
    Translational Research Laboratory IDIBELL, Institut Catala d Oncologia, L Hospitalet de Llobregat, Spain
    Radiat Oncol 6:6. 2011
    ..We investigated the mechanisms of this fragmentation with the principal aim of eliminating it in order to improve the estimation of radiation-induced DNA repair...
  6. ncbi Cetuximab may inhibit tumor growth and angiogenesis induced by ionizing radiation: a preclinical rationale for maintenance treatment after radiotherapy
    Gemma Pueyo
    Laboratori de Recerca Translacional IDIBELL, Catalan Institute of Oncology, L Hospitalet de Llobregat, Spain
    Oncologist 15:976-86. 2010
    ..The aims of this study were to preclinically evaluate the efficacy of cetuximab maintenance after radiotherapy and eventually determine its mechanisms of action...
  7. ncbi Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma
    Margarita Majem
    Department of Medical Oncology, L Hospitalet de Llobregat, Barcelona, Spain
    Laryngoscope 116:1651-6. 2006
    ..The value of induction chemotherapy in larynx-preservation therapies remains unknown. Hyperfractionation radiotherapy might improve disease-free survival...